These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 20559994)

  • 1. The many faces of hypertrophic cardiomyopathy: from developmental biology to clinical practice.
    Olivotto I; Girolami F; Nistri S; Rossi A; Rega L; Garbini F; Grifoni C; Cecchi F; Yacoub MH
    J Cardiovasc Transl Res; 2009 Dec; 2(4):349-67. PubMed ID: 20559994
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Developmental origins of hypertrophic cardiomyopathy phenotypes: a unifying hypothesis.
    Olivotto I; Cecchi F; Poggesi C; Yacoub MH
    Nat Rev Cardiol; 2009 Apr; 6(4):317-21. PubMed ID: 19352336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of animal models in HCM research.
    Shephard R; Semsarian C
    J Cardiovasc Transl Res; 2009 Dec; 2(4):471-82. PubMed ID: 20560005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical pathology of subaortic septal myectomy: histology skips over clinical diagnosis.
    Abecasis J; Gouveia R; Castro M; Andrade MJ; Ribeiras R; Ramos S; Abecasis M; Cardim N; Gil V
    Cardiovasc Pathol; 2018; 33():32-38. PubMed ID: 29414430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.
    Hagège AA; Bruneval P; Levine RA; Desnos M; Neamatalla H; Judge DP
    J Cardiovasc Transl Res; 2011 Dec; 4(6):757-66. PubMed ID: 21909825
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk stratification in hypertrophic cardiomyopathy: time for renewal?
    Pacileo G; Salerno G; Gravino R; Calabrò R; Elliott PM
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):319-25. PubMed ID: 22885536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertrophic cardiomyopathy: the early years.
    Braunwald E
    J Cardiovasc Transl Res; 2009 Dec; 2(4):341-8. PubMed ID: 20559993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The current and emerging role of cardiovascular magnetic resonance imaging in hypertrophic cardiomyopathy.
    Maron MS
    J Cardiovasc Transl Res; 2009 Dec; 2(4):415-25. PubMed ID: 20560000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Peculiarities of morphology and mechanisms of pathogenesis of hypertrophic cardiomyopathy].
    Chudinovskikh IuA; Eremeeva MV; Sukhacheva TV
    Kardiologiia; 2011; 51(2):81-8. PubMed ID: 21627604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertrophic cardiomyopathy: preclinical and early phenotype.
    Ho CY
    J Cardiovasc Transl Res; 2009 Dec; 2(4):462-70. PubMed ID: 20560004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel α-Actin Gene Mutation p.(Ala21Val) Causing Familial Hypertrophic Cardiomyopathy, Myocardial Noncompaction, and Transmural Crypts. Clinical-Pathologic Correlation.
    Frustaci A; De Luca A; Guida V; Biagini T; Mazza T; Gaudio C; Letizia C; Russo MA; Galea N; Chimenti C
    J Am Heart Assoc; 2018 Feb; 7(4):. PubMed ID: 29440008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging cardiac morphology in hypertrophic cardiomyopathy: recent advances.
    Reichek N
    Curr Opin Cardiol; 2015 Sep; 30(5):461-7. PubMed ID: 26154073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subaortic and mid-ventricular obstructive hypertrophic cardiomyopathy with an apical aneurysm: a case report.
    Cianciulli TF; Saccheri MC; Konopka IV; Serans DF; Acunzo RS; Escudero AM; Masoli OH; Prezioso HA
    Cardiovasc Ultrasound; 2006 Mar; 4():15. PubMed ID: 16553961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral valve abnormalities identified by cardiovascular magnetic resonance represent a primary phenotypic expression of hypertrophic cardiomyopathy.
    Maron MS; Olivotto I; Harrigan C; Appelbaum E; Gibson CM; Lesser JR; Haas TS; Udelson JE; Manning WJ; Maron BJ
    Circulation; 2011 Jul; 124(1):40-7. PubMed ID: 21670234
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypertrophic Cardiomyopathy　- A Heterogeneous and Lifelong Disease in the Real World.
    Kitaoka H; Kubo T; Doi YL
    Circ J; 2020 Jul; 84(8):1218-1226. PubMed ID: 32669480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial bridging does not predict sudden death in children with hypertrophic cardiomyopathy but is associated with more severe cardiac disease.
    Mohiddin SA; Begley D; Shih J; Fananapazir L
    J Am Coll Cardiol; 2000 Dec; 36(7):2270-8. PubMed ID: 11127472
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.
    Nucifora G; Muser D; Gianfagna P; Morocutti G; Proclemer A
    Int J Cardiovasc Imaging; 2015 Dec; 31(8):1603-10. PubMed ID: 26210792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of familial hypertrophic cardiomyopathy: from mutation to bedside.
    Brouwer WP; van Dijk SJ; Stienen GJ; van Rossum AC; van der Velden J; Germans T
    Eur J Clin Invest; 2011 May; 41(5):568-78. PubMed ID: 21158848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypertrophic Cardiomyopathy: Genetics, Pathogenesis, Clinical Manifestations, Diagnosis, and Therapy.
    Marian AJ; Braunwald E
    Circ Res; 2017 Sep; 121(7):749-770. PubMed ID: 28912181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy: part 1 - introduction, pathology and pathophysiology.
    Varma PK; Neema PK
    Ann Card Anaesth; 2014; 17(2):118-24. PubMed ID: 24732610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.